SNSS News and Press, Viracta Therapeutics Inc Com From 08/28/20

Volatility watch: Options volatility is running very high on Whiting Petroleum (NYSE: WLL ) , Sunesis Pharmaceuticals (NASDAQ: SNSS ) and Lipocine (NASDAQ: LPCN ) heading into next week, while notable short interest jumps have been seen with Macerich (NYSE: MAC ) , Teladoc (NYSE: T...

Sunesis Pharmaceuticals, Inc. (SNSS) Q2 2020 Earnings Conference Call August 11, 2020 4:30 PM ET Company Participants Par Hyare - Investor Relations Dayton Misfeldt - Interim Chief Executive Officer Judy Fox - Chief Scientific Officer, Executive Vice President, Research & D...

Sunesis Pharmaceuticals (NASDAQ: SNSS ) : Q2 GAAP EPS of -$0.06 in-line. More news on: Sunesis Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

SOUTH SAN FRANCISCO, Calif., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today reported financial results for the second quarter ended June 30, 2020. Loss from operations for the three months ended June 30, 2020 was $6.3 million. As of&...

SOUTH SAN FRANCISCO, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that it will host a conference call on Tuesday, August 11 th , 2020 at 4:30 p.m. Eastern Time to discuss corporate updates and financial results for the second quarter...

Are These On Your List Of Penny Stocks To Buy Or Sell This Week? Last week was one wild week for penny stocks . While I won’t argue that July had been a hot and cold month for small-caps, the final days were definitely some of the most active. It really kicked off with the massive news...

Sunesis Pharmaceuticals (NASDAQ: SNSS ) has priced 52,173,913 common shares at $0.23/share, for gross proceeds of ~$12M. More news on: Sunesis Pharmaceuticals, Inc., Healthcare stocks news, , Stocks on the move, Read more ...

SOUTH SAN FRANCISCO, Calif., July 29, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced the pricing of an underwritten public offering of 52,173,913 shares of its common stock. The public offering price of each share of common stock is $0.23. Sunesis ex...

SOUTH SAN FRANCISCO, Calif., July 28, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock, in an underwritten public offering. There can be no assurance as...

With a goal of sharpening its focus on candidate SNS-510, Sunesis Pharmaceuticals (NASDAQ: SNSS ) announces a workforce reduction of about 30%. The downsizing should be completed this quarter and will extend its cash runway into Q2 2021. More news on: Sunesis Pharmaceuticals, Inc., Taked...